>
Why You're Losing Muscle as You Age - And How to Stop It
Sarcopenia is one of the most prevalent yet consistently underdiagnosed conditions in clinical practice across India. Patients present with fatigue, reduced mobility, and recurrent falls - yet the underlying cause, progressive skeletal muscle loss, is rarely documented or directly addressed. Understanding the condition clearly, and knowing what practical interventions actually work, is increasingly essential for any clinician managing patients over the age of 50.
When Does Muscle Loss Begin?
Earlier than most clinicians discuss with patients. Skeletal muscle mass begins declining from the early 30s at a rate of approximately 0.5% to 1% per year. After the age of 60, this accelerates to around 2% annually, with muscle strength declining at a faster rate of roughly 3% per year. By the time a patient reaches their late 60s, they may have lost 30 to 40% of their peak muscle mass - entirely through biological processes rather than disease or injury.
The World Health Organisation formally recognised sarcopenia as a disease in 2016, assigning it an ICD-10 code. Despite this, it remains significantly underscreened in primary and secondary care settings in India, where cereal-dominant diets and increasingly sedentary lifestyles create conditions highly conducive to accelerated muscle loss.
The Underlying Mechanisms
Sarcopenia is multifactorial. Several converging processes drive it simultaneously, which is why single-intervention approaches rarely produce adequate results.
Anabolic resistance is central to the condition. In younger adults, dietary protein reliably stimulates muscle protein synthesis. With age, this anabolic response becomes blunted - older adults require significantly higher protein intake simply to maintain existing muscle mass, let alone rebuild it. The standard dietary recommendation of 0.8 g per kg per day is now considered insufficient for patients over 60.
Hormonal decline compounds the problem. Falling testosterone in men and oestrogen in women both reduce the anabolic stimulus to muscle. Growth hormone secretion - which drives nocturnal muscle repair - also declines progressively, diminishing the body's capacity to use the overnight fasting window for tissue maintenance.
Chronic low-grade inflammation, sometimes termed inflammaging, is an independent driver of muscle catabolism. Elevated inflammatory cytokines, particularly IL-6 and TNF-alpha, directly suppress muscle protein synthesis whilst accelerating protein breakdown. This is clinically relevant in patients who already carry an inflammatory burden - those with rheumatoid arthritis, COPD, chronic kidney disease, or type 2 diabetes.
Physical inactivity removes the primary mechanical stimulus for muscle maintenance. Without sufficient resistance loading, the body has no biological rationale to sustain metabolically expensive muscle tissue and progressively reduces it.
Vitamin D deficiency deserves specific mention in the Indian context. Despite adequate sunlight, deficiency is widespread owing to indoor lifestyles, skin coverage, and poor dietary sources. Vitamin D receptors are expressed on skeletal muscle cells and directly influence muscle protein synthesis and fibre type composition. Deficiency independently accelerates both mass loss and functional decline.
Recognising It in Clinical Practice
The clinical presentation is often subtle and easily attributed to other causes. Key indicators to screen for include reduced handgrip strength, slower gait speed, difficulty rising from a chair without arm support, and self-reported fatigue disproportionate to activity level.
Formal assessment tools are practical and require minimal equipment. The SARC-F questionnaire is a validated five-item screening tool suitable for routine use. Handgrip dynamometry provides an objective strength measure. The Timed Up and Go test assesses functional mobility. Where available, DEXA scanning remains the gold standard for measuring muscle mass directly.
Clinicians should be particularly vigilant in patients presenting with recurrent falls, unexplained weight loss, worsening glycaemic control, or difficulty with activities of daily living - as sarcopenia frequently underlies or exacerbates each of these presentations.
Evidence-Based Interventions
The clinical evidence is clear that sarcopenia is neither inevitable nor irreversible. Meaningful improvement in muscle mass, strength, and function has been demonstrated in patients well into their 80s when appropriate interventions are implemented.
Protein intake is the primary nutritional intervention. Current guidelines recommend 1.2 to 1.5 g per kg of body weight daily for adults over 60, rising to 1.5 to 2.0 g per kg in sarcopenic patients or those who are largely inactive. Protein timing is clinically significant - pre-sleep protein consumption has been shown in multiple randomised controlled trials to stimulate overnight muscle protein synthesis substantially, exploiting the nocturnal growth hormone window. For most older Indian patients whose diets are cereal-dominant, meeting these targets through food alone is unrealistic. A high-quality protein supplement taken before sleep is a practical and evidence-supported recommendation.
Progressive resistance exercise remains the most potent non-pharmacological stimulus for muscle preservation and growth at any age. A structured programme of two to three sessions weekly, incorporating compound movements with progressive loading, produces measurable gains in muscle mass and functional strength. Patients without gym access can achieve adequate stimulus through bodyweight exercise and resistance bands when coached appropriately.
Vitamin D and calcium supplementation should follow testing. In deficient patients - the majority in India - restoring levels above 30 ng/mL has been shown to improve muscle function and reduce fall risk independently of other interventions.
Sleep quality is frequently overlooked. The majority of muscle protein synthesis occurs during slow-wave sleep. Patients with disrupted or insufficient sleep show faster rates of muscle loss, and addressing sleep hygiene is a simple adjunct to nutritional and exercise interventions.
A Practical Note for Clinicians
Sarcopenia ( Muscle loss ) sits across specialities and consequently tends to fall between them. Geriatricians, orthopaedic surgeons, endocrinologists, and general practitioners all see patients whose presentations are shaped by underlying muscle loss - yet formal diagnosis and management rarely follow. Building a brief sarcopenia screen into consultations for patients over 55, particularly those with diabetes, chronic inflammatory conditions, or recurrent falls, would identify a significant number of patients currently being managed for consequences rather than causes.
The condition is common, underdiagnosed, and eminently treatable. Identifying it earlier makes a material difference to patient outcomes.